Oncologix Tech Inc (OCLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 02-2009 | 11-2008 | 08-2008 | 05-2008 | 02-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | 10 | 2 | 10 |
| Other current assets | 50 | 70 | 80 | 98 | 140 |
| TOTAL | $50 | $70 | $90 | $100 | $150 |
| Non-Current Assets | |||||
| PPE Net | 20 | 20 | 20 | 20 | 220 |
| Investments And Advances | 3 | 0 | 0 | 0 | 10 |
| Other Non-Current Assets | 30 | 120 | 142 | 170 | 30 |
| TOTAL | $53 | $140 | $162 | $190 | $260 |
| Total Assets | $90 | $190 | $240 | $290 | $360 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 450 | 360 | 260 | 170 | 270 |
| Accrued Expenses | 160 | 120 | 120 | 230 | 190 |
| Other current liabilities | 1 | 90 | 90 | 200 | 0 |
| TOTAL | $3,130 | $3,040 | $1,920 | $3,420 | $3,310 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 810 | 740 | 670 |
| TOTAL | $N/A | $N/A | $810 | $740 | $670 |
| Total Liabilities | $3,130 | $3,040 | $2,730 | $4,160 | $3,980 |
| Shareholders' Equity | |||||
| Common Shares | 120 | 120 | 110 | 70 | 70 |
| Retained earnings | -55,240 | -55,110 | -54,490 | -52,870 | -52,300 |
| Other shareholders' equity | 10 | 0 | 10 | 290 | 10 |
| TOTAL | $-3,040 | $-2,840 | $-2,490 | $-3,870 | $-3,620 |
| Total Liabilities And Equity | $90 | $200 | $240 | $290 | $360 |